- call +1-201-465-4211
- email sales@mrinsights.biz
Drug used for respiratory disease.
Scope of the Report:
Major factors contributing to the growth of the global respiratory drug market include increasing prevalence of chronic respiratory diseases such as asthma and COPD.
The worldwide market for Respiratory Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Respiratory Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GSK
Boehringer Ingelheim
AstraZeneca
Merck
Novartis
Omron
Sunovion
Air Liquide
Aradigm
Baxter
Beximco Pharmaceuticals
Compumedics
Pfizer
Draeger
Roche
Fisher & Paykel Healthcare
GE Healthcare
Genentech
Grifols
Hamilton Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Advair
Symbicort turbuhaler
Spiriva
Xolair
Ventolin
Pulmicort
Orkambi
Relvar/breo ellipta
Singulair
Esbriet
Market Segment by Applications, can be divided into
Hospitals
Home care
There are 15 Chapters to deeply display the global Respiratory Drug market.
Chapter 1, to describe Respiratory Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Respiratory Drug, with sales, revenue, and price of Respiratory Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Respiratory Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Respiratory Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Respiratory Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Respiratory Drug Introduction
1.2 Market Analysis by Type
1.2.1 Advair
1.2.2 Symbicort turbuhaler
1.2.3 Spiriva
1.2.4 Xolair
1.2.5 Ventolin
1.2.6 Pulmicort
1.2.7 Orkambi
1.2.8 Relvar/breo ellipta
1.2.9 Singulair
1.2.10 Esbriet
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Home care
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Respiratory Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boehringer Ingelheim
2.2.1 Business Overview
2.2.2 Respiratory Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Ingelheim Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Respiratory Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Respiratory Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Respiratory Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Omron
2.6.1 Business Overview
2.6.2 Respiratory Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Omron Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sunovion
2.7.1 Business Overview
2.7.2 Respiratory Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sunovion Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Air Liquide
2.8.1 Business Overview
2.8.2 Respiratory Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Air Liquide Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aradigm
2.9.1 Business Overview
2.9.2 Respiratory Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aradigm Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Baxter
2.10.1 Business Overview
2.10.2 Respiratory Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Baxter Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Beximco Pharmaceuticals
2.11.1 Business Overview
2.11.2 Respiratory Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Beximco Pharmaceuticals Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Compumedics
2.12.1 Business Overview
2.12.2 Respiratory Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Compumedics Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Pfizer
2.13.1 Business Overview
2.13.2 Respiratory Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Pfizer Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Draeger
2.14.1 Business Overview
2.14.2 Respiratory Drug Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Draeger Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche
2.15.1 Business Overview
2.15.2 Respiratory Drug Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Roche Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Fisher & Paykel Healthcare
2.16.1 Business Overview
2.16.2 Respiratory Drug Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Fisher & Paykel Healthcare Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 GE Healthcare
2.17.1 Business Overview
2.17.2 Respiratory Drug Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 GE Healthcare Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Genentech
2.18.1 Business Overview
2.18.2 Respiratory Drug Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Genentech Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Grifols
2.19.1 Business Overview
2.19.2 Respiratory Drug Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Grifols Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Hamilton Medical
2.20.1 Business Overview
2.20.2 Respiratory Drug Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Hamilton Medical Respiratory Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Respiratory Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Respiratory Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Respiratory Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Respiratory Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Respiratory Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Respiratory Drug Market Analysis by Regions
4.1 Global Respiratory Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Respiratory Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Respiratory Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Respiratory Drug Sales and Growth Rate (2013-2018)
4.3 Europe Respiratory Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Respiratory Drug Sales and Growth Rate (2013-2018)
4.5 South America Respiratory Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Respiratory Drug Sales and Growth Rate (2013-2018)
5 North America Respiratory Drug by Countries
5.1 North America Respiratory Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Respiratory Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Respiratory Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Respiratory Drug Sales and Growth Rate (2013-2018)
5.3 Canada Respiratory Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Respiratory Drug Sales and Growth Rate (2013-2018)
6 Europe Respiratory Drug by Countries
6.1 Europe Respiratory Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Respiratory Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Respiratory Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Respiratory Drug Sales and Growth Rate (2013-2018)
6.3 UK Respiratory Drug Sales and Growth Rate (2013-2018)
6.4 France Respiratory Drug Sales and Growth Rate (2013-2018)
6.5 Russia Respiratory Drug Sales and Growth Rate (2013-2018)
6.6 Italy Respiratory Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Respiratory Drug by Countries
7.1 Asia-Pacific Respiratory Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Respiratory Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Respiratory Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Respiratory Drug Sales and Growth Rate (2013-2018)
7.3 Japan Respiratory Drug Sales and Growth Rate (2013-2018)
7.4 Korea Respiratory Drug Sales and Growth Rate (2013-2018)
7.5 India Respiratory Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Respiratory Drug Sales and Growth Rate (2013-2018)
8 South America Respiratory Drug by Countries
8.1 South America Respiratory Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Respiratory Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Respiratory Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Respiratory Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Respiratory Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Respiratory Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Respiratory Drug by Countries
9.1 Middle East and Africa Respiratory Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Respiratory Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Respiratory Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Respiratory Drug Sales and Growth Rate (2013-2018)
9.3 UAE Respiratory Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Respiratory Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Respiratory Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Respiratory Drug Sales and Growth Rate (2013-2018)
10 Global Respiratory Drug Market Segment by Type
10.1 Global Respiratory Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Respiratory Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Respiratory Drug Revenue and Market Share by Type (2013-2018)
10.2 Advair Sales Growth and Price
10.2.1 Global Advair Sales Growth (2013-2018)
10.2.2 Global Advair Price (2013-2018)
10.3 Symbicort turbuhaler Sales Growth and Price
10.3.1 Global Symbicort turbuhaler Sales Growth (2013-2018)
10.3.2 Global Symbicort turbuhaler Price (2013-2018)
10.4 Spiriva Sales Growth and Price
10.4.1 Global Spiriva Sales Growth (2013-2018)
10.4.2 Global Spiriva Price (2013-2018)
10.5 Xolair Sales Growth and Price
10.5.1 Global Xolair Sales Growth (2013-2018)
10.5.2 Global Xolair Price (2013-2018)
10.6 Ventolin Sales Growth and Price
10.6.1 Global Ventolin Sales Growth (2013-2018)
10.6.2 Global Ventolin Price (2013-2018)
10.7 Pulmicort Sales Growth and Price
10.7.1 Global Pulmicort Sales Growth (2013-2018)
10.7.2 Global Pulmicort Price (2013-2018)
10.8 Orkambi Sales Growth and Price
10.8.1 Global Orkambi Sales Growth (2013-2018)
10.8.2 Global Orkambi Price (2013-2018)
10.9 Relvar/breo ellipta Sales Growth and Price
10.9.1 Global Relvar/breo ellipta Sales Growth (2013-2018)
10.9.2 Global Relvar/breo ellipta Price (2013-2018)
10.10 Singulair Sales Growth and Price
10.10.1 Global Singulair Sales Growth (2013-2018)
10.10.2 Global Singulair Price (2013-2018)
10.11 Esbriet Sales Growth and Price
10.11.1 Global Esbriet Sales Growth (2013-2018)
10.11.2 Global Esbriet Price (2013-2018)
11 Global Respiratory Drug Market Segment by Application
11.1 Global Respiratory Drug Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Home care Sales Growth (2013-2018)
12 Respiratory Drug Market Forecast (2018-2023)
12.1 Global Respiratory Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Respiratory Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Respiratory Drug Market Forecast (2018-2023)
12.2.2 Europe Respiratory Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Respiratory Drug Market Forecast (2018-2023)
12.2.4 South America Respiratory Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Respiratory Drug Market Forecast (2018-2023)
12.3 Respiratory Drug Market Forecast by Type (2018-2023)
12.3.1 Global Respiratory Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Respiratory Drug Market Share Forecast by Type (2018-2023)
12.4 Respiratory Drug Market Forecast by Application (2018-2023)
12.4.1 Global Respiratory Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Respiratory Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Respiratory Drug Picture
Table Product Specifications of Respiratory Drug
Figure Global Sales Market Share of Respiratory Drug by Types in 2017
Table Re
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
